Rezolute, Inc. earnings releases RZLT

Annual Quarterly

Rezolute, Inc. last reported quarterly results on May 12, 2026, for Q3 FY2026 (the quarter ended Mar 31, 2026): diluted EPS of -$0.16. It usually reports 37–43 days after a quarter ends.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 37–43 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released	Quarter	Revenue	Net income	Diluted EPS
May 12, 2026 42 days after quarter end	Q3 FY2026 ended Mar 31, 2026	—	-16 +14.5%	-0.16 +40.7%
Feb 12, 2026 43 days after quarter end	Q2 FY2026 ended Dec 31, 2025	—	-23 -44.8%	-0.22 +0.0%
Nov 6, 2025 37 days after quarter end	Q1 FY2026 ended Sep 30, 2025	—	-18 -18.0%	-0.18 +18.2%
May 13, 2025 43 days after quarter end	Q3 FY2025 ended Mar 31, 2025	—	-19 -10.9%	-0.27 +20.6%
Feb 12, 2025 43 days after quarter end	Q2 FY2025 ended Dec 31, 2024	—	-16 -13.1%	-0.22 +18.5%
Nov 7, 2024 38 days after quarter end	Q1 FY2025 ended Sep 30, 2024	—	-15 -5.9%	-0.22 +21.4%
May 15, 2024 45 days after quarter end	— ended Mar 31, 2024	—	—	—
Feb 13, 2024 44 days after quarter end	— ended Dec 31, 2023	—	—	—

Company profile

Industry: Pharmaceutical Preparations (SIC 2834)
Listed as: RZLT (Nasdaq)
Fiscal year ends: June 30
Incorporated in: NV
Headquarters: Redwood City, CA
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 1509261
Former names: AntriaBio, Inc. (until Dec 7, 2017); FITS MY STYLE INC (until Jan 11, 2013)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.